¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Ç¥"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
standardized mortality ratio
Ç¥ÁØÈ»ç¸Áºñ
standardized natural increase rate
Ç¥ÁØÈÀÚ¿¬Áõ°¡À²
standardized birth rate
Ç¥ÁØÈÃâ»ý·ü
label
Ç¥Áö, À̸§Ç¥
labeling
Ç¥Áö, À̸§Ç¥´Þ±â
marker rescue
Ç¥Áö±¸Á¶
marker gene
Ç¥ÁöÀ¯ÀüÀÚ
labeled antigen
Ç¥ÁöÇ׿ø
labeled antibody
Ç¥ÁöÇ×ü
expressed emotion
Ç¥Ãâ°¨Á¤
lamellar keratoplasty
Ç¥Ãþ°¢¸·À̽Ä(¼ú)
superficial cleavage
Ç¥ÃþºÐÇÒ
shave biopsy
Ç¥Ãþ»ý°Ë
lamellar hole
Ç¥Ãþ¿ø°ø, ºÒ¿ÏÀü¿ø°ø
shave excision
Ç¥ÃþÀýÁ¦
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
graph
µµÇ¥, ±×¸²
graph paper
µµÇ¥Áö
gray scale display
ȸ»öÁ¶Ç¥½Ã
hyperplastic epidermolysis bullosa
Áõ½Ä¹°ÁýÇ¥Çǹڸ®Áõ
health indicator
º¸°ÇÁöÇ¥, °Ç°ÁöÇ¥
hemizona assay index
¹ÝÅõ¸í¶ìÃøÁ¤ÁöÇ¥
hepatitis B surface antigen
BÇü°£¿°Ç¥¸éÇ׿ø
hereditary leptocytosis
À¯ÀüÇ¥ÀûÀûÇ÷±¸Áõ
household sample survey
°¡±¸Ç¥º»Á¶»ç
iodinated
¿ä¿ÀµåÇ¥Áö-
image display
¿µ»óÇ¥½Ã
image labeling
¿µ»óºÎÈ£È, ¿µ»óÇ¥Áö
imaging parameter
¿µ»óÁöÇ¥, ¿µ»óº¯¼ö
Ishihara plate
À̽ÃÇ϶ó»ö°¢°Ë»çÇ¥
isometric chart
µîô¼ºµµÇ¥
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
type species
Ç¥ÁرÕÁ¾
type strain
Ç¥ÁرÕÁÖ
culture type
Ç¥ÁرÕÁÖ, ±âÁØÁÖ
reference strain
Ç¥ÁرÕÁÖ, Ç¥ÁØÁÖ
type culture collection
Ç¥ÁرÕÁÖ¼ö·Ï
test phantom
Ç¥ÁظðÇü
standard limb lead
Ç¥ÁØ»çÁöÀü±Ø
standard condition
Ç¥ÁØ»óÅÂ
standard electrocardiographic lead
Ç¥ÁؽÉÀüµµÀ¯µµ
standard error
Ç¥ÁØ¿ÀÂ÷
standard solution
Ç¥ÁØ¿ë¾×
reference tone
Ç¥ÁØÀ½
standard double two step test
Ç¥ÁØÀÌÁßÀ̴ܰè°Ë»ç
substandard
Ç¥ÁØÀÌÇÏ
standard population
Ç¥ÁØÀα¸
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
direct smear
Á÷Á¢¹Ù¸¥Ç¥º»
direct fecal smear
Á÷Á¢´ëº¯¹Ù¸¥Ç¥º»
direct saline smear
Á÷Á¢»ý¸®½Ä¿°¼ö¹Ù¸¥Ç¥º»
display gray
ȸ»öÇ¥½Ã
distance mark
°Å¸®Ç¥½Ã
double sampling
ÀÌÂ÷Ç¥º»ÃßÃâ, ÀÌÁßÇ¥º»(¹ý)
gray scale display
ȸ»öÁ¶Ç¥½Ã
image display
¿µ»óÇ¥½Ã
length tension diagram
±æÀÌÀå·Â±×¸²Ç¥
nominal standard dose
¸í¸ñÇ¥Áؼ±·®
persistent superficial dermatitis
Áö¼ÓÇ¥ÀçÇǺο°
phase display
À§»óÇ¥½Ã
phocomelic dwarf
¹Ù´ÙÇ¥¹ü³ÀåÀÌ
pressure volume diagram
¾Ð·Â¿ëÀû±×¸²Ç¥
real time display
½Ç½Ã°£Ç¥½Ã, ½ÇÁ¦½Ã°£Ç¥½Ã
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
immunoglobulin, surface
¼¼Æ÷Ç¥¸é ¸é¿ª±Û·ÎºÒ¸°
index card
Áöħǥ(̤̬̰), Áö¼öÇ¥(̤Ëà̰).
indicator
ÁöÇ¥
indicator organism
ÁöÇ¥±Õ(ò¦øöж).
indicator organism
ÁöÇ¥±Õ(ò¦øöж).
indicator virus
±âÁعÙÀÌ·¯½º, Ç¥ÁعÙÀÌ·¯½º
peroxidase label[l]ing
°ú»êÈÈ¿¼ÒÇ¥Áö
persistent superficial dermatitis
Áö¼Ó¼º Ç¥À缺 ÇǺο°
phallic symbol
À½°æÇ¥»ó(ëäÌìøúßÚ).
phan
¿ÜÀûÇ¥Çö(èâîÜøúúÞ).
phase display
À§»ó Ç¥½Ã
phocomelia
¹Ù´ÙÇ¥¹ü¹ßÁõ
phocomelia
ÇØÇ¥»óÁöÁõ(úøûßÒò¶ñø), ´ÜÁöÁõ(Óò¶ñø)
phocomelic dwarf
ÇØÇ¥»óÁö¼º ¼ÒÀÎÁõ(úøûßÒò¶àõ á³ìÑñø), ´ÜÁö¼º ¼ÒÀÎÁõ(Óò¶ñø á³ìÑñø)
phocomelus
ÇØÇ¥»óÁöü(úøûßÒò¶ô÷)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
bleaching fluid
Ç¥¹é¾×(ø÷ÛÜäû).
bleaching solution
Ç¥¹é¿ë¾×.
whitener
Ç¥¹éÁ¦
bleach
Ç¥¹éÁ¦(ø÷ÛÜð¥).
bleaching agent
Ç¥¹éÁ¦.
leopard skin
Ç¥¹ü ÇǺÎ
esophagus,leopard-spotting
Ç¥¹ü¹ÝÁ¡
sample
Ç¥º»
sample volume
Ç¥º» ¿ëÀû (øöÜâ é»îÝ)
sampling frequency
Ç¥º» Á֯ļö
sample volume size
Ç¥º» üÀû (øöÜâ ô÷îÝ) Å©±â
specimen
Ç¥º»(øöÜâ), °Ë»ç¹°(ËþÞÛÚª)
number of sample
Ç¥º»¼ö(̰ËÓËà).
ideative apraxia
Ç¥»ó½ÇÇàÁõ(øúßÚã÷ú¼ñø)
self-as-representation
Ç¥»óÀ¸·ÎÀÇ ÀÚ±â
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
cationic surfactant
¾çÀÌ¿ÂÇ¥¸éȰ¼º¾à(åÕ¡øúØüüÀàõå·).
cell labelling technique
¼¼Æ÷Ç¥Áö±â¹ý
cell surface characteristic
¼¼Æ÷Ç¥¸éƯ¼º
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cell, null
¹«Ç¥Áö¼¼Æ÷
cell, target
Ç¥Àû¼¼Æ÷
chart
ȯÀÚ±â·ÏÁö, µµÇ¥, ÇØµµ.
check list
ý¸®½ºÆ®, Á¡°ËÇ¥(ËøË§Ì°).
chronic superficial gastritis
¸¸¼ºÇ¥À缺 À§¿°(¡øúî¤àõêÖæú).
circumlocution
¿ìȸÀû Ç¥Çö
clinical target volume, CTV
ÀÓ»óÇ¥ÀûüÀû
cluster designation (CD)
¼¼Æ÷Ç¥¸éÇ׿ø±º (CD)
codocyte= target cell
Ç¥Àû¼¼Æ÷
color doppler flow mapping
»ö (ßä) µµÇ÷¯ Ç÷·ùÇ¥½Ã (úì×µøúãÆ)
combined graph
È¥ÇÕµµÇ¥(̴̰ËÀ̰).
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
6
ÄÚµå
¿µ¹®
ÇѱÛ
Q97.8
Other specified sex chromosome abnormalities, female phenotype
±âŸ ¸í½ÃµÈ ¿©¼ºÀÇ Ç¥ÇöÇü ¼º¿°»öü ÀÌ»ó
Q97.9
Sex chromosome abnormality, female phenotype, unspecified
»ó¼¼ºÒ¸íÀÇ ¿©¼ºÀÇ Ç¥ÇöÇü ¼º¿°»öü ÀÌ»ó
Q98
Other sex chromosome abnormalities, male phenotype, NEC
´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ³²¼ºÀÇ Ç¥ÇöÇüÀÇ ±âŸ ¼º¿°»öü ÀÌ»ó
Q98.8
Other specified sex chromosome abnormalities, male phenotype
±âŸ ¸í½ÃµÈ ³²¼ºÀÇ Ç¥ÇöÇü ¼º¿°»öü ÀÌ»ó
Q98.9
Sex chromosome abnormality, male phenotype, unspecified
»ó¼¼ºÒ¸íÀÇ ³²¼ºÀÇ Ç¥ÇöÇü ¼º¿°»öü ÀÌ»ó
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
¼³¸í
epidermolytic palmoplantar keratoderma
Ç¥ÇÇ ¹Ú¸®¼º ¼Õ¹ß¹Ù´Ú °¢ÇÇÁõ
epidermolytic
Ç¥ÇÇ ¹Ú¸®¼º, Ç¥ÇÇ ¿ëÇØ¼º
epidermophytosis
Ç¥ÇÇ »ç»ó±ÕÁõ
Áø±Õ·ù, ƯÈ÷
epidermic graft
Ç¥ÇÇ À̽Ä, Ç¥ÇÇ ÀÌ½ÄÆí
¸Ç»ì¿¡ ÀÌ½ÄµÈ Ç¥ÇÇ Æí.
epidermatomycosis
Ç¥ÇÇ Áø±ÕÁõ
epidermomycosis
Ç¥ÇÇ Áø±ÕÁõ
staphylococcus epidermidis
Ç¥ÇÇ Æ÷µµ»ó ±¸±Õ
»ö¼Ò ºñ»ê»ý, coagulase À½¼º, mannitol À½¼ºÀÇ ºñº´¿ø¼º ¹Ì»ý¹°·Î¼, ÈçÈ÷ ÇǺο¡¼ º¼ ¼ö ÀÖ´Ù.
epidermal system
Ç¥Çǰè
acrosyringeal nevus
Ç¥Çdz» ÇѰü ¸ð¹Ý
epidermal inclusion cyst
Ç¥ÇǼº ºÀÀÔ ³¶Á¾
»óÇÇ ³¶Á¾ÀÇ ÀÏÁ¾À¸·Î ³¶º®ÀÌ Ç¥ÇÇ¿Í °ÅÀÇ Â÷À̰¡ ¾øÀ¸¸ç ÃþÆÇ »ó °¢Áú·Î Â÷ ÀÖ´Ù.
epidermic
Ç¥ÇÇÀÇ
epidermosis
Ç¥ÇÇÁ¾Áõ
subepidermal nodular fibrosis
Ç¥ÇÇÇÏ °áÀý¼º ¼¶À¯Áõ
subcuticular :
subcuticular suture
Ç¥ÇÇÇÏ ºÀÇÕ, ÇÇÇϳ» ºÀÇÕ
¿Ã¢ÀÌ ±íÀ» ¶§ »ç°ÀÌ »ý±âÁö ¾Êµµ·Ï Çϱâ À§ÇÏ¿© Á¶Á÷ ±í¼÷ÇÑ °÷À» ºÀÇÕÇÒ ¶§ ½ÃÇàÇÏ´Â ¹æ¹ý.
subepidermal
Ç¥ÇÇÇÏ, Ç¥ÇÇÇÏÀÇ
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
¼³¸í
exfoliative toxin
Ç¥ÇÇ ¹Ú¸® µ¶¼Ò
expression
Ç¥Á¤, Ç¥Çö
À°Ã¼Àû, °¨Á¤Àû »óÅ¿¡ µû¶ó °áÁ¤µÇ´Â ¾ó±¼ÀÇ ¿Ü°ß.
expressive or signal output process
Ç¥Çö¼º, ȤÀº ½ÅÈ£ÀÇ Ãâ·ÂÈ °úÁ¤
expressiveness
Ç¥Çö¼º
extracellular current
¼¼Ç¥¿Ü Àü·ù
facet
¸é, ÀÛÀº Ç¥¸é, ¼Ò °üÀý ¸é, ôÃß °üÀý µ¹±â, ±³ÇÕ ¼Ò¸é, ¿À¸ñ
°æÁ¶Á÷ ¸é »óÀÇ ÀÛ°í ¸Å²öÇÑ Æò¸é.
fatty coating of surface
Ç¥¸éÀÌ Áö¹æÀ¸·Î µ¤Çô ÀÖ´Â
fluorescein-labelled antibody
Çü±¤ Ç¥Áö Ç×ü
fresh specimen
½Å¼± Ç¥º»
haploidentity
´ÜÀÏ Ç׿ø Ç¥Çö»ó
ÀÏÁ¤ÇÑ Æ¯ÀÌ ºÎÀ§¿¡¼ µ¿ÀÏ Ç׿ø Ç¥ÇöÇüÀ» °®´Â »óÅÂ. Àå±â ÀÌ½Ä ¿¬±¸¿¡¼ Àå±â °ø¿©ÀÚ-¼ö·ÉÀÚ Â¦¸ÂÃã¿¡ ´ëÇÏ¿© ¸»ÇÑ´Ù.
heterophany
ÀÌÇüÁú Ç¥Çö, ÀÌÇüÁú Ç¥Çö¼º
°°Àº »óÅÂÀÌ¸é¼ ³ªÅ¸³»´Â Ç¥ÇöÀÌ ´Ù¸¥ °Í.
high surface
°íÇ¥¸é
idee
°ü³ä, Ç¥»ó
imaging parameter
¿µ»ó ÁöÇ¥, ¿µ»ó º¯¼ö
indicator
ÁöÇ¥, Áö½Ã¾à
1. ¿øÀÎ, º´¸®, Ä¡·á ¶Ç´Â Áúȯ ¹ßÀÛÀÇ ÀüÁ¶¸¦ ÁöÀû ȤÀº Áö½ÃÇÏ´Â ÁõÈÄ ¶Ç´Â »óȲÀ¸·Î¼ Áöħ ȤÀº °æ°í°¡ µÈ´Ù. 2. Áö½Ã±â, Ç¥½Ã±â, ¾Ð·Â Áö½Ã±â¸¦ ³ªÅ¸³»´Â ¸». 3.
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
phonography
Ç¥À½ ¹®ÀÚ¿¡ ÀÇÇÑ ¼Ó±â
phonotypy
Ç¥À½½Ä ¼Ó±â¹ý(Àμâ¹ý)
ideogram
Ç¥ÀÇ ¹®ÀÚ
ideograph
Ç¥ÀÇ ¹®ÀÚ
ideogram
Ç¥ÀÇ ¹®ÀÚ
ideography
Ç¥ÀÇ ¹®ÀÚÇÐ;Ç¥ÀÇ ¹®ÀÚ »ó¿ë
tabular
Ç¥ÀÇ;Ç¥·ÎÇÑ;¾ãÀº ÆÇÀÚ(¸ð¾ç)ÀÇ
ideographic
Ç¥ÀÇÀûÀÎ
ideographical
Ç¥ÀÇÀûÀÎ
humoresque
Ç¥Àϰî
emblematist
Ç¥Àå Á¦ÀÛÀÚ;±âÀå(Ç¥Àå)°í¾ÈÀÚ;¿ìÀÇÈ È°¡
whitlow
Ç¥Àú
target
Ç¥Àû
cockshot
Ç¥Àû ¶³¾î¶ß¸®±â
cockshy
Ç¥Àû ¶³¾î¶ß¸®±â
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
marking
Ç¥
milieu
ȯ°æ; Ç¥Çö¼ö´Ü
nomogram
°è»ê µµÇ¥
nomograph
°è»ê µµÇ¥
on
...ÀÇ Ç¥¸é¿¡
ostensible
Ç¥¸é»óÀÇ
ostensibly
Ç¥¸é»ó
paid
pay[(ÁÖÀÇ,Á¸°æ,)Ç¥
pard
Ç¥¹ü
paster
ºÙÀÌ´Â µüÁö(¿ìÇ¥ µî)
periphrasis
¿¡µÎ¸£´Â Ç¥Çö
perispome
¾ï¾ç À½Ç¥°¡ ÀÖ´Â
perispomenon
¾ï¾ç À½Ç¥°¡ ÀÖ´Â
philatelist
¿ìÇ¥¼öÁý°¡
plagiarism
Ç¥Àý
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½